Federal Health Grants

The purpose of this funding opportunity is to develop artificial intelligence tools and experimental assays to identify new pharmacotherapeutics with lower toxicity and higher efficacy for substance use disorders (SUD) Areas of interest include but are not limited to: 1) Development of AI tools to identify potential target combinations, design new molecules, conduct virtual preclinical studies to predict efficacy and toxicity, and model in vitro and in vivo polypharmacology 2) Development of assays to assess the effects of compounds on multiple targets or functions

This funding opportunity is designed to support the Frederic Rieders Family Renaissance Foundation in advancing research, education, and reporting on emerging synthetic drugs and their impact on public health and safety.

This grant provides funding to eligible institutions, particularly Historically Black Colleges and Universities, Tribal Colleges and Universities, and IDeA program participants, to develop programs that train diverse clinician-scientists who can address the nation's biomedical research needs.

This grant provides funding to support the Tanzanian government's efforts to strengthen public health systems, improve disease detection and response, and enhance laboratory capabilities to better manage health threats.

This funding opportunity supports U.S. institutions in developing educational programs that provide undergraduate and early-stage graduate students with hands-on research experiences in kidney technology development and entrepreneurship.

This funding opportunity supports innovative research and development in biological technologies that enhance national security, targeting universities, nonprofits, small businesses, and industry participants, particularly those with commercial potential.

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) is soliciting Transformative Research Award applications to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research that has the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies related to Down syndrome. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. Applications are welcome in all topics relevant to Down syndrome-related research or its co-occurring conditions. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in research related to Down syndrome.

The National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) with other NIH Institutes and Centers (ICs), intends to publish a new Notice of Funding Opportunity (NOFO) to solicit applications for multi-PI team-based, challenging, high impact projects to improve understanding of mechanisms of chronic pain in children and adolescents and to accelerate the development of age appropriate, patient/family centered prevention and therapeutic approaches. This research will seek to advance an integrated understanding of the biological, psychological, and social factors that contribute to pediatric chronic pain. NIH is interested in pain research in infants, children, and adolescents that includes those with intellectual and physical disabilities and/or those who experience health disparities (e.g., diverse race/ethnicity, sexual and gender minorities, socioeconomically disadvantaged, medically underserved communities, people with limited English proficiency). NIH encourages applicants to consider community-engaged research and interdisciplinary, collaborative applications to be developed in partnership with patient communities and/or community organizations where possible. The long-term goal is to develop improved knowledge of specific pediatric pain conditions as well as pain associated with diverse diseases/disorders, to improve understanding of pain in the context of child development and to facilitate the stratification of patients with specific pain conditions and co-morbidities to accelerate chronic pain prevention and therapeutic clinical trials. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in May 2024 with an expected application due date in Fall 2024. This NOFO will utilize the UC2 Research Project Cooperative Agreements activity code. Details of the planned NOFO are provided below.

This funding opportunity provides administrative support to an organization dedicated to increasing the number of Native Hawaiian health care professionals through scholarships for students pursuing health care careers in Hawaii.

The "Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology" grant aims to fund well-established structural biology resources at synchrotron facilities, with the goal of maintaining or upgrading them to current best practices, promoting their availability to the biomedical research community, and providing user training and support.

This grant provides funding for researchers to investigate the harmful effects and underlying mechanisms of acute exposure to ultra-potent synthetic opioids, aiming to develop effective treatments and countermeasures for public health emergencies.

This grant provides funding for research aimed at improving the prevention and treatment of bacterial STIs in adolescents and mothers affected by HIV, targeting organizations capable of addressing these public health challenges.

This funding opportunity provides financial support to small businesses developing new medications for treating alcohol use disorder and related organ damage, with a focus on advancing these therapies toward FDA approval.

This grant provides funding to healthcare organizations and community-based entities to improve mental health and substance use care for women, particularly those affected by the COVID-19 pandemic, through training, technical assistance, and the development of resources.

The purpose of the Promote Mental Health Among the Health Professional Workforce (PMHW) program is to support health care entities, including entities that provide health care services, such as hospitals, community health centers, and rural health clinics, or medical professional associations, to promote wellness, resilience, and mental health of the health care professional workforce using established or enhanced evidence-based or evidence-informed programs to transform organizational cultures.

This funding opportunity supports researchers investigating the causes of structural birth defects by exploring genetic, environmental, and biological factors, encouraging innovative approaches and collaboration across various scientific disciplines.

This funding opportunity provides financial support to various organizations, including local governments and nonprofits, to hire and train professionals who conduct sexual assault forensic exams, particularly in underserved communities.

This funding opportunity provides financial support to state governments, local agencies, and tribal organizations to develop and enhance community-based mental health services for children and youth with serious emotional disturbances.

The purpose of the program is to promote the delivery of health care services to rural underserved populations in the rural Northern Border Regional Commission (NBRC) service area of Maine, New Hampshire, New York, and Vermont. Through a consortia of local health care and social service providers, communities can develop innovative approaches to challenges related to specific health needs that expand clinical and service capacity. This program supports HRSA's collaboration with the Northern Border Regional Commission.

This funding opportunity provides financial support for the early development of innovative drugs aimed at preventing, slowing, or treating Alzheimer's disease and its symptoms.